Felicia Angus is an accomplished pharmaceutical industry leading expert in Quality Assurance and Quality Control. With extensive experience in executing and monitoring compliance with regulatory requirements from agencies such as the FDA, EMA, DEA, Canadian, Japanese, Swedish authorities, ICH, and 21 CFR 820, Felicia brings a wealth of knowledge and expertise to her role. She has a deep understanding of the regulatory requirements necessary to meet standards for cGMPs, cGLPs, FDA regulations, and guidance documents. Felicia has a strong background in hosting FDA inspections and providing recommendations for corrective actions to companies that have received Consent Decrees and Warning Letters. Her experience spans various compliance-related positions at notable companies including Novartis Animal Health, Biogen Idec, GlaxoSmithKline, Abraxis Bioscience, Danchem Technologies, Wyeth, and Pfizer. Current Education: • Master of Science in Management and Leadership (in progress) from Western Governors University Previous Education: • Bachelor of Science in Chemistry from North Carolina Agricultural & Technical State University Experience: • Extensive experience in Quality Assurance and Quality Control • Expertise in regulatory compliance with FDA, EMA, DEA, Canadian, Japanese, Swedish, ICH, and 21 CFR 820 requirements • In-depth knowledge of cGMPs, cGLPs, FDA regulations, and guidance documents • Proven track record in hosting FDA inspections and advising on corrective actions for Consent Decrees and Warning Letters • Held compliance-related positions at: o Novartis Animal Health o Biogen Idec o GlaxoSmithKline o Abraxis Bioscience o Danchem Technologies o Wyeth o Pfizer Current Residence: • Greensboro, North Carolina Felicia’s extensive background and ongoing commitment to education make her a valuable resource for anyone looking to deepen their understanding of quality assurance and regulatory compliance in the pharmaceutical industry.